Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
NCT: NCT06046833 · RECRUITING
Brief Summary
A pilot study to evaluate and compare glucose metrics using a real-time continuous glucose monitor (FreeStyle Libre 3 sensor) between patients with diabetes and gastroparesis and those with diabetes without gastroparesis.
Frequently Asked Questions
What is Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes?
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes is a clinical trial registered under NCT06046833. Current status: RECRUITING.
What is the status of NCT06046833?
The current status of NCT06046833 (Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes) is: RECRUITING.
When did Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes start?
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes started on 2024-01-08.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.